Market Research Report
Global Opioids Drug Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||750061|
|Published||Content info||166 Pages
Delivery time: 1-2 business days
|Global Opioids Drug Market Forecast 2019-2027|
|Published: November 29, 2018||Content info: 166 Pages||
The global opioids drugs market is anticipated to grow at a CAGR of 2.52% between 2019 and 2027. Opioids are narcotic drugs and mostly directed for pain management. Increasing case of road accidents & surgical procedures are the main drivers that are propagating the global market growth for opioids drugs.
The opioid drugs are commonly used for alleviating the post-operative pains caused by surgical procedures. Opioid drugs are approved by FDA in the United States with ADF labeling and are currently marketed in North America. The market is segmented by products and applications, out of which, the former's oxycodone sub-segment is estimated to hold the highest market share in 2018. Growing demand for palliative care that aims to improve the quality of life for the patient suffering from terminal illness by implementing the use of opioid drugs is further driving the said market's growth. The growing opioid addiction crisis is leading to submission of lawsuits against pharmaceuticals companies who are manufacturing the opioid drugs.
The global market for opioid drugs is geographically segmented into four regions, namely, North America, Asia-Pacific, Europe and countries from the Rest of the World. The North American economy holds the largest share for the market by revenue in the forecast years. The recurrently increasing geriatric population who are prone to irreversible and incurable disorders and chronic diseases are further enhancing the demand for pain management treatments in the market. Investments from local, regional players in the development of abuse-deterrent morphine drug are attributing for a high growth rate of morphine drug in the region.
Acura Pharmaceuticals, Inc., Allergan PLC, BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Daiichi Sankyo, Inc., Egalet Corp., Hikma Pharmaceuticals PLC, Indivior, Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lannett Co. Inc., Lupin Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Sun Pharmaceutical Industries Limited (Sun Pharma) and Teva Pharmaceutical Industries Ltd. are some of the key market players who are dominating the global opioids market.